Compass Therapeutics, Inc. (CMPX) — SC 13G/A Filings
All SC 13G/A filings from Compass Therapeutics, Inc.. Browse 3 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (3)
- SC 13G/A Filing — Nov 14, 2024
-
FMR LLC & Abigail Johnson Trim Compass Therapeutics Stake to 3.57%
— Feb 9, 2024 Risk: medium
FMR LLC, a major investment firm, and its Chair and CEO, Abigail P. Johnson, have updated their ownership in Compass Therapeutics, Inc. This amendment, filed on -
Adage Capital Partners Reports 8.0% Stake in Compass Therapeutics
— Feb 7, 2024
Adage Capital Partners, L.P. filed an amended SC 13G/A on February 7, 2024, indicating a change in their beneficial ownership of Compass Therapeutics, Inc. comm
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX